The Corporate Development Interview: M&A In The Room

A corporate development interview tests whether you can run a deal end to end: find targets worth pursuing, diagnose what could go wrong in due diligence, value the business three ways, and judge whether the acquisition actually creates value for your company. Corporate development interview questions blend the technical core of M&A (valuation and modeling) with strategic judgment about why a deal makes sense at all, so prepare for both the math and the story.

Corporate development sits on the buy side inside an operating company, sourcing and executing acquisitions, divestitures, and partnerships in service of strategy. That framing matters in the interview: unlike a banker pitching any deal, you are expected to ask whether a target fits the company and earns its price, not just whether a transaction can be done.

Deal Sourcing And Strategic Fit

Early questions probe how you would find and screen targets.

• Thesis first. A good acquisition serves a strategy: enter a market, add a capability, acquire technology, consolidate, or remove a competitor. Start from the gap you are filling, then look for targets that fill it.
• Screening. Build a pipeline from market maps, banker inbound, and proactive outreach, then filter on strategic fit, size, valuation, and integration difficulty.
• Build versus buy versus partner. Be ready to argue why buying beats building it yourself or partnering, including the cost and time of integration.

Example question: "We want to expand into an adjacent market. Walk me through how you would decide whether to acquire your way in." Lead with the strategic rationale and the alternatives, then move to which targets fit and what you would pay, rather than jumping straight to a model.

Due Diligence: Know Where Deals Break

Due diligence is the structured investigation of a target's financial, operational, legal, and commercial reality to surface risks and confirm the thesis before you commit. Interviewers want to see that you know where value leaks.

• Financial. Quality of earnings, revenue durability and customer concentration, working capital needs, debt and off-balance-sheet liabilities, and whether reported EBITDA is real and repeatable.
• Commercial. Market size, competitive position, and whether the growth in the model is defensible.
• Operational. Management depth, systems, supply chain, and the integration effort the synergies depend on.
• Legal and compliance. Contracts, change-of-control clauses, litigation, IP ownership, and regulatory exposure.

A sharp point to make: diligence tests the assumptions in your model. If it shows customer concentration or one-off revenue, the valuation has to move.

Valuation: The Three Core Methods

You will be asked to value a business, and the expected answer is the standard triangulation.

• Comparable companies (trading comps). Value the target off valuation multiples of similar public companies, reflecting how markets price comparable businesses today.
• Precedent transactions. Look at multiples paid in recent completed or announced deals for similar companies, adjusting for size, market conditions, and synergies. These usually run higher than trading comps because they include a control premium.
• Discounted cash flow (DCF). Project the target's free cash flow, discount it to present value at a rate reflecting its risk (the weighted average cost of capital), and add a terminal value. The intrinsic method, and the most sensitive to assumptions.

No single method is the answer; you triangulate. Expect the follow-up "which do you trust most and why," where the right move is to discuss the trade-offs rather than crown one method.

Enterprise Value, Equity Value, And The Bridge

This is the most common technical trap, so be exact.

• Enterprise value is the value of the whole operating business to all capital providers.
• Equity value is what the shareholders receive, and it is roughly enterprise value minus net debt (and minus preferred and minority interest), where net debt is total debt minus cash.

A classic test: "Does raising new debt increase enterprise value?" The answer is no. The cash raised offsets the new debt, so net debt is unchanged and enterprise value does not move. Getting this right signals you actually understand the structure rather than reciting formulas.

Accretion, Dilution, And Synergies

For a public acquirer, the gut-check is whether the deal raises or lowers earnings per share.

• A deal is accretive if pro forma EPS rises and dilutive if it falls. Cash and debt-financed deals are cheaper on EPS but add interest cost; stock-financed deals add shares.
• Synergies are the value created by combining: cost synergies (overlapping functions) are more credible, while revenue synergies are speculative and get haircut hard. Typical cost-synergy assumptions run in the single-digit-to-low-double-digit percent of the target's cost base, higher for overlapping businesses.

Example question: "All else equal, is a stock or cash deal more likely to be accretive?" Cash or debt is usually more accretive when the after-tax cost of that financing is below the target's earnings yield, but you should name the trade-offs, including the debt capacity and risk you take on.

How To Rehearse

Say the valuation methods, the enterprise-to-equity bridge, and the accretion/dilution logic out loud until they are automatic, because the interviewer will interrupt and probe. A voice-driven trainer like Mythic Intel can research the corporate development role, verify the technical answers you give, run the valuation and diligence cases, and grade your spoken responses on accuracy and structure before you sit in front of the deal team.